Skip to content

Archives: PHARMACEUTICALS

indonesia-halal-nutraceuticals-market-inkwood-research

INDONESIA HALAL NUTRACEUTICALS MARKET FORECAST 2025-2032

COUNTRY, PHARMACEUTICALS, Upcoming ReportsBy ShreyasJanuary 9, 2025

The Indonesia halal nutraceuticals market is anticipated to rise with a CAGR of 7.85%, during the forecast period of 2025-2032. Request a free sample report.

pre-eclampsia-early-stage-therapy

PRE-ECLAMPSIA – EARLY-STAGE THERAPY – PIPELINE INSIGHT 2024

PHARMACEUTICALSBy ShreyasSeptember 19, 2024

Pre-eclampsia is a common pregnancy-related complication, affecting 2–15% of pregnancies. Read more about Pre-Eclampsia Early-stage Therapy Pipeline report

dry-age-related-macular-degeneration-early-stage-therapy

DRY AGE MACULAR DEGENERATION (DRY AMD) – EARLY-STAGE THERAPY – PIPELINE INSIGHT 2024

PHARMACEUTICALSBy ShreyasSeptember 19, 2024

Age-related macular degeneration (AMD) is a progressive eye disease primarily affecting individuals over the age of 50. Read more on Dry AMD Early-stage Therapy

CNTX-4975

CNTX-4975 OSTEOARTHRITIS DRUG PIPELINE – MARKET INSIGHTS AND FORECASTS UPTO 2032

NICHE REPORTS, PHARMACEUTICALSBy ShreyasSeptember 16, 2024

CNTX-4975 is currently being evaluated as a treatment for moderate to severe knee osteoarthritis (OA) pain. Get more insights into our latest pipeline reports

ELIXCYTE-pipeline

ELIXCYTE OSTEOARTHRITIS DRUG PIPELINE – MARKET INSIGHTS AND FORECASTS UPTO 2032

NICHE REPORTS, PHARMACEUTICALSBy ShreyasSeptember 16, 2024

ELIXCYTE is an allogeneic stem cell product derived from adipose tissue, designed to regulate the immune system. Read more about Elixcyte Osteoarthritis reports

←1
23
…45678…
91011121314151617181920212223242526272829303132333435363738394041424344
45→
Go to Top
X
 
Download PDF Now!